News Releases
Sep 9 2005
Peregrine Pharmaceuticals Announces First Quarter 2006 Financial Results
Aug 29 2005
Peregrine Pharmaceuticals and New Approaches to Brain Tumor Therapy (NABTT) Consortium Initiate Cotara(R) Brain Cancer Trial
Aug 25 2005
Peregrine Pharmaceuticals Enters Into Licensing Agreement With Medarex to Develop Vascular Targeting Agents
Aug 8 2005
Peregrine Pharmaceuticals Initiates Tarvacin(TM) Phase I Hepatitis C Virus Trial
Jul 21 2005
Peregrine Pharmaceuticals and the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Sign Agreement for Anti-Viral Testing
Jul 14 2005
Peregrine Pharmaceuticals Announces Fiscal Year 2005 Financial Results and Operational Highlights
Jun 23 2005
Peregrine Pharmaceuticals Announces $6.7 Million Investment From One Institutional Investor
Jun 22 2005
Peregrine Pharmaceuticals Presents Data Supporting Broad Spectrum Anti-Viral Potential of Tarvacin(TM) at BIO 2005
Jun 10 2005
Peregrine Pharmaceuticals Opens Patient Enrollment for Its Tarvacin(TM) Phase I Solid Cancer Therapy Clinical Trial
Jun 8 2005
Peregrine Pharmaceuticals to Present at Rodman and Renshaw Techvest 2nd Annual Security & Connectivity Investor Conference